Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.07
+0.21 (2.37%)
Mar 2, 2026, 4:00 PM EST - Market closed
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $240.28 million as of March 3, 2026. Its market cap has increased by 31.66% in one year.
Market Cap
240.28M
Enterprise Value
207.85M
1-Year Change
31.66%
Ranking
Category
Stock Price
$9.07
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $240.28M, an increase of 314.24%. That is a compound annual growth rate of 41.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 234.72M | 21.37% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
| Feb 4, 2022 | 58.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 247.32M |
| Achieve Life Sciences | 242.75M |
| Surrozen | 238.29M |
| Crescent Biopharma | 236.36M |
| Arcturus Therapeutics Holdings | 233.85M |
| Camp4 Therapeutics | 232.95M |
| Protalix BioTherapeutics | 231.61M |
| Voyager Therapeutics | 227.96M |